Answers are grounded in this paper and cite their sources.
Objective To understand the efficacy of intravenous calcium for the prevention of postpartum hemorrhage in cesarean deliveries. This systematic review and meta-analysis assessed outcomes such as blood loss, intravenous fluids, change in hematocrit, blood transfusion and second-line uterotonic requirement to guide clinical decision-making. Data sources Web-based databases were systematically searched using relevant keywords to identify all published studies on intravenous calcium during cesarean delivery for the prevention of postpartum hemorrhage. Study eligibility criteria Randomized control trials including pregnant individuals undergoing cesarean section were eligible. Studies compared intravenous calcium with placebo and/or usual care and reported at least one of the outcomes studied. Study appraisal and synthesis methods Two authors independently screened studies, extracted data, and assessed risk of bias using the Cochrane Risk of Bias tool. Continuous outcomes were analyzed using random-effects meta-analysis, with weighted mean differences and 95% confidence intervals (CI). Likewise, dichotomous outcomes were analysed using random-effects meta-analysis, with risk ratio and 95%CI. Heterogeneity was assessed using the I 2 statistic. Results Six trials comprising 746 patients were included: 382 (51.21%) received intravenous calcium, and 364 (48.79%) placebo and/or usual care. The evidence indicated a clinical minor but statistically relevant reduction that in blood loss and intravenous fluids requirement (WMD = -46.36 mL; 95%CI, −68.12 to −24.60; 95%PI, −84.13 to −8.59; p < 0.0001; I 2 = 50.8% and WMD = WMD = -52.44 mL; 95%CI, −82.55 to –22.32; 95%PI, −91.93 to −12.94; p = 0.0006; I 2 = 0%) respectively. Second-line uterotonic requirement showed a low-certainty statistical relevant result (RR = 0.64; 95%CI, 0.43 to 0.94; 95%PI, 0.26 to 1.57; p = 0.02; I 2 = 30%). Conclusions Intravenous Calcium might reduce the need for second-line uterotonics administration, and a statistically significant but clinically minor reduction in blood loss and intravenous fluids. However, the clinical magnitude of these effects remains uncertain.
No takes yet. Share an insight, caveat, or question.
Nakayama et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: